fb
X
X
Tired?
Unfocused?
Off your game?
Read our free, updated as of Mar 3, 2022, Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
YES, SEND ME THE REPORT !
Meet Dr K !
Chris Kacher
  • Nuclear physicist
  • Stock & crypto market wizard
  • Blockchain builder
  • Bestselling author
  • Top 40 charted musician
  • Biohacker
  • Former computer hacker
YES, SEND ME THE FILE !
YES, SEND ME BOTH !
Your email will always remain private.

MLR - PMP 2/11/14

Major averages rose on lighter volume. The new Federal Reserve Chairperson Janet Yellin is expected to continue to stay the course when she testifies today. Under Bernanke, the Fed would keep rates low for an extended period while continuing to taper with the intention to stop quantitative easing by the end of 2014. Of course, this is predicated on a recovering economy. Yellin has expressed deep concerns regarding unemployment thus on this issue, she is perceived as a dove, willing to keep the printing presses rolling if it can further reduce unemployment well below the 6.5% target. That said, on the inflation issue, she is perceived to be a hawk as she says inflation must be controlled. The tightrope the Fed must continue to walk is to reduce QE while making sure the economy continues to recover, and hoping inflation remains subdued.

Fireeye (FEYE) had a pocket pivot breakout. Group rank 4, sales up sharply. We reported on FEYE when it had its buyable gap up on January 3. If you are using the 7-week rule, you would still hold a position in this stock as it violated its 10-day moving average within 7 weeks, so you would switch to using the 50-day moving average as your selling guide. FEYE announces earnings today after the close.

Biotech Regeneron Pharmaceuticals (REGN) had a pocket pivot breakout. Group rank 2, pretax margin 38.5%, ROE 61.3%. Biotechs as a whole continue to outperform.

This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
FOR OUR FREE MARKET LAB REPORT :
Copyright ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy